Craneware Plc (GB:CRW)
LSE:CRW
Want to see GB:CRW full AI Analyst Report?
CRW Stock Chart & Stats
2230.00 p
-80.00 p(-3.72%)
At close: 4:00 PM EST
2230.00 p
-80.00 p(-3.72%)
Day’s Range― - ―
52-Week Range1,272.34 p - 2,644.00 p
Previous CloseN/A
Volume2.39K
Average Volume (3M)71.71K
Market Cap
£487.83M
Enterprise Value678.81M
Total Cash (Recent Filing)£40.96M
Total Debt (Recent Filing)£26.91M
Price to Earnings (P/E)30.0
Beta0.78
Next Earnings
Sep 22, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.66%
Share Statistics
EPS (TTM)0.63
Shares Outstanding34,237,150
10 Day Avg. Volume64,377
30 Day Avg. Volume71,707
Financial Highlights & Ratios
PEG Ratio0.76
Price to Book (P/B)3.07
Price to Sales (P/S)5.04
P/FCF Ratio17.45
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)1.22
Revenue Forecast (FY)£227.00M
Bulls Say, Bears Say
Bulls Say
Recurring SaaS Subscription ModelCraneware's core revenue derives from recurring SaaS contracts plus implementation and ongoing support. This durable pricing mix provides predictable revenue streams, supports multi-year customer relationships, and enables steady renewal and cross-sell opportunities to fund long-term product investment.
Very High Gross Margins (>85%)Gross margins above 85% reflect a high-margin software and analytics business, giving structural earnings resiliency. Such margins allow sustained reinvestment in R&D and sales, absorb pricing pressure, and support operating leverage as recurring revenues scale over multiple reporting periods.
Conservative Leverage / Strong Balance SheetA debt-to-equity of ~0.09 denotes a conservative capital structure that preserves financial flexibility. Low leverage reduces refinancing risk, supports steady dividend or buyback policy, and gives scope to fund product development or M&A without jeopardizing liquidity in downturns.
Bears Say
Declining Free Cash Flow GrowthA recent -13.4% drop in free cash flow growth weakens internal funding capacity for capex, dividends, or strategic investments. Even with healthy operating cash conversion, a sustained FCF decline would constrain discretionary spending and reduce margin of safety for long-term initiatives.
Modest Net Profitability And Low ROEDespite strong gross margins, modest net margins and a low ROE indicate limited conversion of operating profits into shareholder returns. This structural profitability gap can cap long-term EPS growth and limit the company's ability to deliver superior returns on invested equity.
Slow Revenue GrowthRevenue growth near ~3-4% is relatively modest for a software provider, limiting operating leverage and scale benefits. Persistently slow top-line expansion constrains long-term margin improvement and reduces the runway for realizing returns from product and market investments.
Craneware News
CRW FAQ
What was Craneware Plc’s price range in the past 12 months?
Craneware Plc lowest share price was 1272.34 p and its highest was 2644.00 p in the past 12 months.
What is Craneware Plc’s market cap?
Craneware Plc’s market cap is £487.83M.
When is Craneware Plc’s upcoming earnings report date?
Craneware Plc’s upcoming earnings report date is Sep 22, 2026 which is in 100 days.
How were Craneware Plc’s earnings last quarter?
Craneware Plc released its earnings results on Mar 02, 2026. The company reported 0.422 p earnings per share for the quarter, beating the consensus estimate of N/A by 0.422 p.
Is Craneware Plc overvalued?
According to Wall Street analysts Craneware Plc’s price is currently Overvalued.
Does Craneware Plc pay dividends?
Craneware Plc pays a Semiannually dividend of 15 p which represents an annual dividend yield of 1.66%. See more information on Craneware Plc dividends here
What is Craneware Plc’s EPS estimate?
Craneware Plc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Craneware Plc have?
Craneware Plc has 34,237,150 shares outstanding.
What happened to Craneware Plc’s price movement after its last earnings report?
Craneware Plc reported an EPS of 0.422 p in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.99%.
Which hedge fund is a major shareholder of Craneware Plc?
Currently, no hedge funds are holding shares in GB:CRW
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Craneware Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-10.04%
12-Months-Change
Fundamentals
Return on Equity
6.65%
Trailing 12-Months
Asset Growth
-13.53%
Trailing 12-Months
Company Description
Craneware Plc
Craneware plc, with its associated entities, is dedicated to creating, distributing, and maintaining cutting-edge software applications tailored for the U.S. healthcare industry. Its extensive suite of products is designed to streamline and improve a wide array of operational functions for healthcare organizations. Among its flagship offerings is the Chargemaster Toolkit, an automated, cloud-hosted platform for charge master administration, crucial for enabling providers to achieve optimal and legitimate revenue reimbursement. Trisus Supply facilitates the identification and resolution of data inconsistencies between disparate systems. The Physician Revenue Toolkit, a Software-as-a-Service (SaaS) solution, empowers the oversight of physician group performance indicators, billing rates, procedural codes, relative value units, and fee schedules. Complementing these are Reference Plus, another SaaS tool for comprehensive chargemaster analytics, and Pharmacy ChargeLink, engineered to bolster charge capture, pricing strategies, and cost control within pharmacy operations. Furthermore, the company offers integration software that autonomously uploads chargemaster modifications to patient billing systems, thereby ensuring billing precision. The Trisus Pricing Analyzer, a SaaS application, streamlines the pricing model development process. Extending its capabilities, Craneware delivers tools for regulatory adherence and financial oversight: InSight Medical Necessity, a SaaS solution for validating the medical necessity required by U.S. payers and for creating advance beneficiary notices; Trisus Claims Informatics, a program that automates the review of claims and coding; and InSight Audit, a browser-based audit management application for healthcare entities to handle governmental and commercial examinations. Additionally, the firm presents Trisus Healthcare Intelligence, a platform for cost analysis and resource optimization; solutions for pricing transparency; and InSight Denials, which facilitates the analysis, tracking, trending, and reporting of denial data, further supported by appeals management services. Beyond its software offerings, Craneware provides comprehensive client success management, specialized consulting, and an array of professional services. The organization also oversees its own sales, marketing efforts, and continuous product and software innovation. Founded in 1999, Craneware plc has its corporate headquarters situated in Edinburgh, United Kingdom.
Technical Analysis
Options Prices
Currently, No data available
---